Integrating CardioOncology Across the Research Pipeline, Policy, and Practice in Australia-An Australian Cardiovascular Alliance Perspective

- Singleton, Anna C., Redfern, Julie, Garvey, Gail, Williams, Trent D., Hunt, Lee, Doyle, Kerry, Figtree, Gemma A., Ngo, Doan T. M., Sverdlov, Aaron L., Australian Cardiovascular Alliance Cardio-Oncology Working Group,, Diaz, Abbey, Koczwara, Bogda, Nicholls, Stephen J., Negishi, Kazuaki, La Gerche, Andre, Playford, David, Conyers, Rachel, Cehic, Daniel A.

Pharmacist-led medication management services: a qualitative exploration of transition-of-care cardiovascular disease patient experiences

- Bennetts, Joshua, White, Jennifer, Croft, Hayley, Cooper, Joyce, McIvor, Dawn, Eadie, Nicholas, Appay, Marcelle, L Sverdlov, Aaron L., Ngo, Doan

Extracellular matrix protein 1 as a mediator of inflammation-to-fibrosis progression after myocardial infarction

- Hardy, Sean

Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative

- Teske, Arco J., Moudgil, Rohit, Sverdlov, Aaron L., Cheng, Richard K., Makhoul, Silvia, Ghosh, Arjun K., Szmit, Sebastian, Zaha, Vlad, Addison, Daniel, Zhang, Lili, Herrmann, Joerg, Chong, Jun H., López-Fernández, Teresa, Agarwala, Vivek, Iakobishvili, Zaza, Guerrero, Patricia, Yang, Eric H., Leja, Monika, Akhter, Nausheen, Guha, Avirup, Okwuosa, Tochukwu M., Silva, Carolina C., Collier, Patrick, Barac, Ana, DeCara, Jeanne, Bauer, Brenton, Lenneman, Carrie E., Sadler, Diego, Brown, Sherry Ann, Deswal, Anita, Neilan, Tomas G., Ganatra, Sarju, Abdel Qadir, Husam, Menon, Venu

Temporal trends in, and associations of, early-career general practitioner prescriptions of second-line Type 2 Diabetes medications, 2010-2018

- Patsan, Irena, Tapley, Amanda, Spike, Neil, FitzGerald, Kristen, Magin, Parker, Davoren, Peter, Fielding, Alison, Holliday, Elizabeth, Ball, Jean, Davey, Andrew, van Driel, Mieke, Turner, Rachel, Mulquiney, Katie

Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance

- Tommasi, S., Elliot, D. J., Hulin, J. A., Lewis, B. C., McEvoy, M., Mangoni, A. A.

Consumer participation in quality improvements for chronic disease care: development and evaluation of an interactive patient-centered survey to identify preferred service initiatives

- Fradgley, Elizabeth A., Paul, Christine L., Bryant, Jamie, Roos, Ian A., Henskens, Frans A., Paul, David J.

Principal component analysis of heart rate variability data in assessing cardiac autonomic neuropathy

- Tarvainen, Mika P., Cornforth, David J., Jelinek, Herbert F,

Computational intelligence methods for the identification of early cardiac autonomic neuropathy

- Cornforth, David, Tarvainen, Mika, Jelinek, Herbert F.

Serum methylarginines and spirometry-measured lung function in older adults

- McEvoy, Mark A., Schofield, Peter W., Attia, John R., Smith, Wayne T., Agho, Kingsley, Mangoni, Arduino A., Soiza, Roy L., Peel, Roseanne, Hancock, Stephen J., Carru, Ciriaco, Zinellu, Angelo

Impact of movement on cardiorespiratory coordination in conscious rats

- Kabir, Muammar M., Nalivaiko, Eugene, Abbott, Derek, Baumert, Mathias

Staff perspectives of a cardiac short stay unit

- Narasimhan, Seshasayee, McKay, Katrina, Attia, John

Direct reconstruction of functional parameters for dynamic SPECT

- Limber, M. A., Limber, M. N., Celler, A., Barney, J S., Borwein, J. M.